Rheumatoid and Inflammatory Arthritis Program

The Yale Rheumatoid Arthritis Program addresses the challenges faced by patients with all forms of inflammatory arthritis. Our program focuses on three components: Patient Care, Patient Education, and Clinical Research designed to advance our knowledge and treatment of arthritis.

Patient Care

The key to effective management of inflammatory arthritis begins with ensuring that the correct diagnosis is made. Our program at Yale-New Haven offers expertise in adult Rheumatology, Laboratory Medicine, and Radiology. We arrive at all decisions about medical therapy in collaboration with our patients; each patient is unique, and we aim to optimize the treatment of each individual. We work closely with our colleagues in Physical and Occupational Therapy to ensure that patients have appropriate guidance in physical activities and rehabilitation if indicated, and Orthopaedic Surgery to ensure they have access to up-to-date approaches in joint surgery if necessary. We believe in the importance of communication with our patients as they develop an understanding of their disease processes and medical therapies. The program is at the Interventional Immunology Center where there is a state of the art infusion center. Referrals to the program can be made through Epic or by faxing patient information and the new patient referral form to 203-785-7053.

Education

One of our main goals is to educate each patient in our best understanding of that individual’s disease, appropriate therapies, and in resources available to those living with inflammatory arthritis. We encourage patients, and their families, to participate in all aspect of decision-making about their disease management. We work together with patients to help them achieve a high quality of life.

Other Sources of Information

Research

Our patients may choose to participate in research studies. Our research is directed at finding better clinical therapies, improving the quality of patients’ lives, increasing our understanding of inflammatory arthritis and our patients’ preferences regarding their treatment.